logo

Last Update

This profile was last updated on 8/18/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Fred Eshelman?

Fred N. Eshelman

Chief Executive Officer

PPD Inc

HQ Phone:  (910) 251-0081

Direct Phone: (910) ***-****direct phone

Email: f***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

PPD Inc

929 North Front Street

Wilmington, North Carolina,28401

United States

Company Description

PPD is a leading global contract research organization providing drug discovery, development and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices ...more

Background Information

Employment History

Chancellor

University of California , San Diego


Chancellor

North Carolina State University


Chancellor

University Professor Of Chemistry


Affiliations

Eshelman Ventures LLC

Founder


University of North Carolina

Board of Trustees


The Medicines Company

Board Member


The Medical Foundation of North Carolina Inc

Executive Committee


Valeant Pharmaceuticals International

Board Member


Innocrin Pharmaceuticals Inc

Board Member


G1 Therapeutics, Inc.

Board Member


Auven Therapeutics

Advisory Board


Neoantigenics Inc

Board Member


Medikidz Limited

Board Member


Cellective BioTherapy Inc

Board Member


Aero MD

Board Member


ProFibrix B.V.

Board Member


GlaxoSmithKline plc

Senior Vice President, Development and Member of the Board of Directors


Debt

Steering Committee Member


Eyenovia , Inc.

Board Member


Meryx , Inc.

Board Member


Dignify Therapeutic , Inc.

Board Member


Non-Employee

Board Member


Targanta Therapeutics Corp.

Board Member


InvestCorrectly

Board Member


Princeton BioPharma Capital Partners LLC

Business Advisory Board Member


Association of Clinical Research Organizations

Board Member


Celtic Therapeutics

Advisory Board Member


Wilmington Chamber of Commerce

Board Member


Visitors

Member of the Pharmacy School's Board


Cellona Therapeutics

Advisory Board Member


Accelerator Corporation

Board Member


University of Cincinnati

Faculty Member


N.C. Medical Foundation

Executive Committee


Computer Solutions

Board Member


Aton Pharma , Inc.

Board Member


School of Ph..

Member


Princeton Pharma Holdings LLC.

Member, Board


Spotlight Health Inc

Board Member


PRIMECYTE , Inc.

Board Member


PPGx

Board Member


Board of Visitors

Member


Gov. Beverly Perdue

Board of Trustees


Can.Board Listed/Public CompaniesThe Medicines Company

Board Member


Pharm

Founder


University of North Carolina

Member of the Board of Governors


Carolina Business Coalition

Board Member


Catalytix Inc

Board of Advisors Member


Oriel Therapeutics Inc.

Board Member


SARCO , Inc.

Chair, Board of Directors


Education

B.S.

Harvard Business School


B.S.

pharmacy

University of North Carolina at Chapel Hill. He


BSc

pharmacy

UNC-CH


BSc

pharmacy

University of North Carolina , Chapel Hill


Graduate of the Owner/President Management program

Harvard Business School


Ph.D.

University of North Carolina-Chapel Hill


Pharm.D.

The School of Pharmacy at UNC Chapel Hill


bachelor's degree

High Point University


bachelor's degree

pharmacy

Carolina


bachelor's degree

pharmacy

UNC Chapel Hill


doctorate

pharmacy

University of Cincinnati


Web References(186 Total References)


Board of Directors | The Medicines Company

www.themedicinescompany.com [cached]

Fredric N. Eshelman, Pharm.D
Non-Executive Chairman, Member of Audit Committee Fredric N. Eshelman has been a director and chairman since August 2015. Dr. Eshelman has more than 35 years of strategic development, executive, operational and financial leadership experience in the pharmaceutical and healthcare industries. Dr. Eshelman was the founder of Pharmaceutical Product Development, Inc. (PPD) and founding chairman of Furiex Pharmaceuticals, Inc. In 2014, Dr. Eshelman founded Eshelman Ventures, LLC, an investment company focused on healthcare companies. From 2009 to 2014, Dr. Eshelman served as Chairman of the Board of Furiex. From 2009 to 2011, he served as Executive Chairman of PPD. He also served as Chief Executive Officer of PPD from 1990 to 2009 and as Vice Chairman of its Board of Directors from 1993 to 2009. Dr. Eshelman currently serves on the board of directors of AeroMD, Cellective Biotherapy, Inc., Dignify Therapeutic, Inc., Eyenovia, Inc., G1 Therapeutics, Inc., Innocrin Pharmaceuticals, Inc., Medikidz USA, Inc., Meryx, Inc. and Neoantigenics LLC and Valeant Pharmaceuticals International, Inc., and the advisory board of Auven Therapeutics. Dr. Eshelman has served on the executive committee of the Medical Foundation of North Carolina, was on the Board of Trustees for UNC-W and in 2011 was appointed by the NC General Assembly to serve on the Board of Governors for the state's multi-campus university system as well as the NC Biotechnology Center. In addition, he chairs the board of visitors for the School of Pharmacy at UNC-CH. One of the top pharmacy programs in the United States, in May 2008 the school was named the UNC Eshelman School of Pharmacy in recognition of his many contributions to the school and the profession. Dr. Eshelman has received many awards including the Davie and Distinguished Service Awards from UNC and Outstanding Alumnus from both the UNC and University of Cincinnati schools of pharmacy, as well as the NC Entrepreneur Hall of Fame Award. He has received the doctor of pharmacy from the University of Cincinnati, completed a residency at Cincinnati General Hospital and a BS in pharmacy from UNC-CH. He is a graduate of the OPM program at Harvard Business School.


Board of Directors | The Medicines Company

profibrix.com [cached]

Fredric N. Eshelman, Pharm.D
Non-Executive Chairman Fredric N. Eshelman has been a director and chairman since August 2015. Dr. Eshelman has more than 35 years of strategic development, executive, operational and financial leadership experience in the pharmaceutical and healthcare industries. Dr. Eshelman was the founder of Pharmaceutical Product Development, Inc. (PPD) and founding chairman of Furiex Pharmaceuticals, Inc. In 2014, Dr. Eshelman founded Eshelman Ventures, LLC, an investment company focused on healthcare companies. From 2009 to 2014, Dr. Eshelman served as Chairman of the Board of Furiex. From 2009 to 2011, he served as Executive Chairman of PPD. He also served as Chief Executive Officer of PPD from 1990 to 2009 and as Vice Chairman of its Board of Directors from 1993 to 2009. Dr. Eshelman currently serves on the board of directors of AeroMD, Cellective Biotherapy, Inc., Dignify Therapeutic, Inc., Eyenovia, Inc., G1 Therapeutics, Inc., Innocrin Pharmaceuticals, Inc., Medikidz USA, Inc., Meryx, Inc. and Neoantigenics LLC, and the advisory board of Auven Therapeutics. Dr. Eshelman has served on the executive committee of the Medical Foundation of North Carolina, was on the Board of Trustees for UNC-W and in 2011 was appointed by the NC General Assembly to serve on the Board of Governors for the state's multi-campus university system as well as the NC Biotechnology Center. In addition, he chairs the board of visitors for the School of Pharmacy at UNC-CH. One of the top pharmacy programs in the United States, in May 2008 the school was named the UNC Eshelman School of Pharmacy in recognition of his many contributions to the school and the profession. Dr. Eshelman has received many awards including the Davie and Distinguished Service Awards from UNC and Outstanding Alumnus from both the UNC and University of Cincinnati schools of pharmacy, as well as the NC Entrepreneur Hall of Fame Award. He has received the doctor of pharmacy from the University of Cincinnati, completed a residency at Cincinnati General Hospital and a BS in pharmacy from UNC-CH. He is a graduate of the OPM program at Harvard Business School.


Dr. Fred Eshelman

www.valeant.com [cached]

Dr. Fred Eshelman
» Dr. Fred Eshelman Dr. Fred Eshelman Corporate Director Dr. Fred Eshelman Dr. Eshelman has been serving on the Board since March 2016 and has more than 35 years of strategic development, executive, operational and financial leadership experience in the pharmaceutical and healthcare industries. He is the founder and former Chief Executive Officer and Executive Chairman of Pharmaceutical Product Development, Inc. (PPD), a global contract pharmaceutical research organization providing drug discovery, development and lifecycle management services. Dr. Eshelman was also the founding chairman of Furiex Pharmaceuticals, Inc., a drug development company that collaborated with pharmaceutical and biotechnology companies to increase the value of their drug candidates by applying an accelerated approach to drug development.


Inside 6 North Carolina VC Deals Announced This Week | ExitEvent

www.exitevent.com [cached]

Well-known biotech executive Fred Eshelman is the company's chief executive officer.
He is the founder of Eshelman Ventures LLC, an investment company primarily interested in private health care companies. Previously he founded and served as CEO of Pharmaceutical Product Development. He also served as founding chairman and largest shareholder of Furiex Pharmaceuticals, which was sold to Forest Labs/Actavis in July 2014.


Briefly Bio | Site Selection Online

siteselection.com [cached]

PPD founder Fred Eshelman has announced a $100-million donation to UNC-Chapel Hill, the largest single gift ever received by the university.
He had already donated $38 million to the school, which in 2008 renamed its School of Pharmacy for him. The commitment will be used to create a center within the school named the Eshelman Institute for Innovation. The institute's goals are to fuel innovation, create jobs and spur economic development in the state and provide faculty with new resources to engage in timely, opportunistic research, education and practice. Fred Eshelman, a 1972 graduate of UNC-Chapel Hill, is founder and former CEO of Pharmaceutical Product Development (PPD) and founding chairman of Furiex Pharmaceuticals.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory